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ABSTRACT  
 
Background: The success rate of Tuberculosis treatment in Indonesia decreased by 81.3% in 
2014, which below the 85% target. The current increasing problem in the developing world is 
multidrug resistance of Tuberculosis (MDR-TB). Many factors may contribute to MDR-TB. At 
the individual level these factors may include adherence to medication, perception of vulne-
rability, seriousness, benefit, barrier, and nutritional status. At the institutional level these 
factors may include the availability of drugs and implementation of DOTS program. This study 
aimed to analyze factors that affect MDR-TB in Surakarta and Ngawi, Indonesia. 
Subjects and Method: This was an observasional analytic study with case control design. It 
was carried out in August-October 2016 in Surakarta and Ngawi, Indonesia. A total of 120 
patients were selected by fixed disease sampling. Another sample of 44 health workers was 
also selected for the study. The endogenous variables: adherence, nutritional status,  and 
implementation of the treatment of DOTS. The exogenous variables: perception of 
vulnerability, seriousness, benefits, barriers, the availability of anti Tuberculosis drugs. The 
data was collected by questionnaire and analyzed by path analysis. 
Results: Nutritional status (b=-2.98; 95% CI=-5.31 to -0.64; p=0.012), adherence to anti 
Tuberculosis drugs (b=-3.38; 95% CI =-5.94 to -0.82; p=0.010), treatment with DOTS for 
MDR TB (b=-0.88; 95% CI=1.43 to 3.18; p=0.456) were associated with MDR-TB. Perceived 
vulnerability (b= 2.81; 95% CI= 0.99 to 4.64; p=0.003), seriousness (b=4.47; 95% CI= 2.38 to 
6.57; p 0.001), benefits (b= 3.4; 95% CI=1.52 to 5.18; p=0.001), barriers (b =-1.81; 95% CI=-
3.48 to -1.39; p=0.034), as well as availability of DOTS treatment (b = 3.14; 95% CI= 0.95 to 
5.32; p=0.002), were associated with adherence to treatment. 
Conclusion: Nutritional status, adherence to treatment, implementation of DOTS strategy 
for MDR-TB affect the risk of MDR TB. Perceived vulnerability, seriousness, benefit, and 
barrier, as well as availability of DOTS treatment, affect adherence to treatment. Partnership 
between patients and health care personnel is recommended to increase the success of TB 
treatment. 
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BACKGROUND 
Pulmonary tuberculosis (TB) is still one of 
the world's health problems although 
control efforts with the Direct Observed 
Treatment Shortcourse (DOTS) strategy 
have been applied in many countries since 
1995 (Erah and Ojieabu, 2009). In 2012, 
pulmonary tuberculosis cases in the world 
were 8.6 million (Kemenkes RI, 2015). 
Based on World Health Organization 
(WHO) data in 2013 there were 9 million 
people of the world have been infected with 
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TB germs (WHO, 2014). While in 2014 
increased to 9.6 million (WHO, 2015). 
 One effort to control TB is by treat-
ment. Indonesia experienced a decrease in 
treatment success rate in 2014 compared to 
the previous 6 years. In 2014, success rate 
was 81.3%. WHO set the standard of 
treatment success rate of 85%. Thus, in 
2014 Indonesia did not reach those 
standards (Ministry of Health RI, 2015). 
 Pulmonary TB drugs should be taken 
by the patient routinely for six consecutive 
months without stopping. If the treatment 
is discontinued for up to six months, the 
patient will recur at any time and the 
bacterium Mycobacterium tuberculosis is 
resistant again and therefore it will cost a 
great deal of money (Faustini et al., 2006). 
In addition, a low nutritional status factor 
in most TB patients will slow the healing 
process and reduce the body's immunity 
that result in increasing the risk of bacteria 
becoming more dangerous or resistant 
(Budiyanto, 2014). The bacteria resistant to 
treatment is known as Multi Drug Resistant 
(MDR). 
 The prevalence of MDR TB cases in 
2010 was 290,000 cases. While Indonesia 
is on 9 level with the number of cases 6,100 
(Ministry of Health RI, 2011). In 2013 
WHO estimates that in Indonesia there are 
6,800 new TB cases with MDR TB in each 
year. An estimated 2% of new TB cases and 
12% of cases of TB treatment are MDR TB 
cases (Kemenkes RI, 2015). 
 Factors affecting MDR rates are the 
availability of sufficient and qualified OAT 
or the OAT availability used for TB therapy 
(Sihombing, 2012). In addition, factors 
contributing to drug resistance in deve-
loping countries include the patient's igno-
rance of his illness, poor adherence, inade-
quate monotherapy or drug regimens, 
inadequate doses, poor instructions, poor 
treatment regimens, less patient motiva-
tions, drug supply irregularity, drug 
availability and drug quality contribute to 
secondary drug resistance (Masniari et al., 
2007). 
 One of the models developed to look 
at the factors that influence a person's 
actions to seek a healthy lifestyle is the 
Health Belief Model (HBM) (Safri et al., 
2014). Judging from HBM theory, indi-
vidual health behavior is influenced the 
perception of susceptibility to a disease, 
perception to seriousness caused by 
disease, gain to conduct suggested health 
behavior and amount of obstacles 
encountered. 
 In 2010, MDR TB treatment program 
was started in Dr. Moewardi, Surakarta. 
Based on preliminary study conducted by 
studyers, MDR TB case in dr. Moewardi 
Surakarta has increased. In 2013 there were 
40 cases and in 2016 there were 100 cases. 
OAT-resistant TB is essentially a result of 
inadequate TB patient’s treatment leading 
to transmission to MDR TB patients to the 
community. The purpose of this study is to 
know the factors that influence MDR TB. 
 
SUBJECTS AND METHOD 
This study is a quantitative study using 
observational analytic design with case 
control approach. The population in this 
study wasTB and MDR TB patients in 
Surakarta and Ngawi. The number of study 
subjects was 164 subjects. The number of 
study subjects for patients was 120 
subjects, while the number of study 
subjects for health workers was 44 subjects 
with fixed disease sampling sample 
techniques. 
Endogenous variables included medi-
cation adherence, implementation of DOTS 
treatment, MDR TB. Exogenous variables 
included perceptions of vulnerability, 
perceptions of seriousness, perception of 
benefits, perception of barriers, availability 
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of OAT and nutritional status. Drug 
compliance was the patient’s willingness to 
obey the rules of medical treatment routine 
and complete. The perception of vulnera-
bility was a positive or negative assessment 
of the risk of experiencing MDR TB. The 
perception of seriousness was the indivi-
dual's subjective perception of how severe 
the physical and social consequences of the 
illness were. Perceiving benefit was the 
patient's perceived belief in the benefits of 
treatment to reduce the risk of MDR TB. 
Perception of barriers was a belief that was 
a constraint or hindrance of patients to 
undergo treatment. The implementation of 
DOTS treatment was a strategy imple-
mented in basic health services to detect 
and cure TB patients. Nutritional status 
was the assessment of the patient's 
nutritional status based on anthropometric 
assessment. All variables used a dichotomy 
scale. Data collection techniques used 
questionnaires. Data analysis used path 
analysis. 
 
RESULT 
1. Characteristics of Study Subjects 
Characteristics of study subjects can be 
seen in Table 1. 
Table 1.The Distribution of MDR TB study subjects 
Characteristic 
Case Control 
n % n % 
Gender     
Man 37 61.7 33 55.0 
Woman 23 38.3 27 45.0 
Age     
< 35 years old 31 51.7 23 38.3 
≥ 35 years old 29 48.3 37 61.7 
Last Education     
Low/Basic (Elementary,Junior) 30 50.0 31 51.7 
High/Continuity (Senior, academic,university) 30  50.0 29 49.3 
Family Income (Rp)     
< 1,500,000/month 53 88.3 45 75.0 
≥1,500,000/month 7 11.7 15 25.0 
Smoking Habit     
Smoking 15 25.0 20 33.3 
Not Smoking 45 75.0 40 66.7 
Alcohol Drinking Habit     
Drinking 5 8.30 3 5.00 
Not Drinking 55 91.7 57 95.0 
History of contact with TB patients     
Ever 20 33.3 17 28.3 
Never 40 66.7 43 71.7 
Long Suffering from TB     
<a year 17 28.3 44 73.3 
≥ a year 43 71.7 16 26.7 
TB Treatment History     
New 16 26.7 50 83.3 
Has Recurred 44 73.3 10 26.7 
Other Diseases Suffered     
No 46 76.7 42 70.0 
Others (HIV, cancer, DM) 14 23.3 18 30.0 
 
Characteristics of the study subjects 
showed that male’s study subjects were 
more than women in the case and control 
group of 61.7% and 55%. Majority case 
group less than 35 years old was 51.7%, 
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while majority control group over the age of 
35 years was 61.7%. 
 The last educational proportions of 
patient study subjects were the same for 
case and control groups. Family income for 
a month in case group and control were 
more than the family income which have 
<Rp 1,500,000/ month that were 88.3% 
and 75%. Most of patients in the case and 
control group had no smoking habits (75% 
and 66.7%) and alcohol consumption of 
91.7% and 95%. Case and control groups 
were largely never in contact with patients 
with previous tuberculosis, 66.7% and 
71.7%. Case groups had tuberculosis disease 
≥ 1 year that is 71.7% and most control 
groups had suffered from tuberculosis <1 
year that is 73.3%. Case group, having 
previous history of tuberculosis treatment 
was more dominant that is 73.3%, while 
control group patients mostly getting 
tuberculosis treatment was 83.3%. Most 
case and control groups did not suffer from 
other illness than tuberculosis of 76.7% and 
70%. Most case and control groups lived in 
a clean environment of 95% and 80%. 
Table 2.The Distribution of study subjects (health workers) 
Characteristic 
Case Control 
n % n % 
Gender     
Man 6 27.3 1 4.5 
Woman 16 72.7 21 95.5 
Age     
< 35 years old 7 31.8 5 22.7 
≥ 35 years old 15 68.2 17 77.3 
Last Education     
Diploma 4 18.2 12 54.5 
S1 3 13.6 2 9.1 
S1+Profesion 13 59.1 8 35.4 
Spesialist 2 9.10 0 0 
Work Duration     
< 5 years 5 22.7 2 9.1 
≥ 5 years 17 77.3 20 90.9 
 
The result of study subject characteristic 
showed that health worker giving tuber-
culosis treatment was more female workers 
in case and control group that was 72.7% 
and 95.5%. Most of the age of health 
workers were over 35 years old in both case 
and control group, 68.2% and 77.3%. The 
most recent education owned by case group 
was mostly S1 + Profession was 59.1% and 
the proportion control group was almost 
the same studysubject as diploma III and S1 
+ Profession, 54.5% and 35.4%. Most of 
case and control groups had worked in 
health care institutions for ≥5 years, 77.3% 
and 90.9%. 
 
2. Path Analysis 
The results of path analysis data process 
used STATA 13, as follows: 
a. Model Specification 
The initial model in path analysis can be 
seen in Figure 1. 
b. Model Identification 
The measured variable was 9, the endoge-
nous variable was 3, the exogenous variable 
was 6, and the parameter number was 9. 
Degree of freedom (df) = (measured varia-
ble number x (measured variable number + 
1) / 2 (endogen variable+ exogenous varia-
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ble+ parameters)= (9x10) / 2 - (3+6+9) 
=27. 
The model identification was obtained 
in df value is over identified which means 
path analysis can be done. 
c. Model and parameter estimation 
compatibility 
Path analysis model made by the researcher 
based on the theory checked its compa-
tibility with the best variable relation model 
based on sample data collected by the 
researcher. 
Picture 2 showed that the results of 
path analysis with STATA 13 resulted in the 
relationship between MDR TB and its risk 
factors.  
 
 
Picture 1. Path analysis with specification model 
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Picture 2. Model with parameter estimation 
  
 The result of coefficient value on each 
variable in each path was a positive 
relationship between perception of suscep-
tibility to adherence to medication 
compliance, which was 2.8, there was a 
positive relationship between perceptions 
of seriousness with medication adherence 
of 4.5, there was a positive relationship 
between the perception of benefits with 
compliance of 3.4, there was a negative 
relationship between the perception of 
obstacles with compliance of drinking drug 
of -1.8. The path coefficient value between 
medication adherences and MDR TB was 
negative at -3.4. The path coefficient value 
between drug availability and MDR of TB 
was positive value at -3.1. The path 
coefficient value between the treatment of 
DOTS and MDR TB was negative at -8.8, 
there was a negative relationship between 
nutritional status and MDR TB at -3. 
 Table 3.The results of risk factor analysis path of Multi Drug Resistant 
Tuberculosis (MDR TB) 
Dependent 
Variable 
 
Independent Variable b 
95% CI  
p Lower 
Limit 
Upper 
Limit 
Direct effect       
MDR TB   Nutritional status (normal) -2.98 -5.31 -0.64 0.012 
MDR TB   Benefit (high) -3.38 -5.94 -0.82 0.010 
MDR TB   DOTS treatment (DOTS) -0.88 -3.18 1.43 0.456 
Indirect effect       
Adherence  Susceptibility (high) 2.81 -0.99 4.64 0.003 
Adherence  Seriousness (high) 4.47 2.38 6.57 <0.001 
Adherence  Benefit (high) 3.35 1.52 5.18 <0.001 
Adherence  Barrier (high) -1.81 -3.48 -0.14 0.034 
DOTS treatment  Drug availability (available) 3.14 0.95 5.32 0.005 
N Observation     = 120 
Log likelihood =-56.73 
 
 
AIC = 135.46 
BIC = 166.13 
   
 
Table 3 showed that the results of calcu-
lations using computer software program 
STATA 13, there was a relationship between 
nutritional status of tuberculosis patients 
and decreased risk logit for MDR TB and 
the relationship was statistically significant. 
Tuberculosis patients with good or normal 
nutritional status had a 2.98 risk logit 
lower than in patients with abnormal nutri-
tional status (b = -2.98; 95% CI = -5.31 to -
0.64; p = 0.012). 
 There was a relationship between 
patient adherence in taking medication and 
decreased risk logit for MDR TB occurrence 
and the relationship was statistically signi-
ficant. Patients who were obedient in taking 
tuberculosis medication had a 3.38 lower 
risk logit than patients who did not adhere 
to taking tuberculosis medication (b = -
3.38; 95% CI = -5.94 to -0.82; p = 0.010). 
 There was a relationship between 
treatment with the DOTS strategy and 
decreased risk logit for MDR TB occurrence 
and the relationship was not statistically 
significant. Medicines who performed 
treatment using the DOTS treatment 
strategy had a 0.88 lower risk logit than the 
non-performing medical personnel using 
the DOTS treatment strategy (b = -0.88; 
95% CI = -3.18 to 1.43; p = 0.456). 
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 There was a relationship between 
susceptibility perceptions and increased 
logit to have patient adherence in taking 
tuberculosis medication and the relation-
ship was statistically significant. Patients 
with high perceptual tuberculosis had a 
2.81 logit risk higher than tuberculosis 
patients with low susceptibility perception 
(b= 2.81; 95% CI= 0.99 to 4.64; p = 0.003). 
 There was a relationship between 
perception of seriousness and increased 
logit to have adherence in taking tuber-
culosis drugs and the relationship was 
statistically significant. Patients with severe 
perception of seriousness had a 4.47 logit 
risk higher than those with a low serious-
ness perception (b = 4.47; 95% CI = 2.38 to 
6.57; p <0.001). 
 There was a relationship between 
beneficial perceptions and increased logit 
to have adherence to tuberculosis drug 
treatment and the relationship was statis-
tically significant. Tuberculosis patients 
with high benefit perceptions had a 3.35 
higher risk logit than tuberculosis patients 
with low benefit perceptions (b = 3.35; 95% 
CI = 1.52 to 5.18; p <0.001). 
 There was a relationship between 
perception of barriers and decreased logit 
to have adherence in taking tuberculosis 
drugs and the relationship was statistically 
significant. Highly perceptual tuberculosis 
patients had a logit risk of 1.81 lower than 
in low-perception tuberculosis patients (b = 
-1.81; 95% CI = -3.48 to -1.39; p = 0.034). 
 There was a relationship between 
drug availability and increased logit in the 
implementation of treatment with the 
DOTS strategy and the relationship was 
statistically significant. Health workers 
providing drugs suitable with the DOTS 
logit risk strategy were 3.14 times higher 
than the health professionals who did not 
provide the medication according to the 
DOTS treatment strategy (b = 3.14; 95% CI 
= 0.95 to 5.32; p = 0.002). 
d. Model Respesification 
The model in this study was due to the 
sample data as indicated by the saturation 
model and also the regression coefficient 
which was more than zero and statistically 
significant, it was not necessary to recreate 
the path analysis model. 
 
DISCUSSION 
1. Relationship between patient 
adherence on taking Tuberculosis 
Drugs and MDR TB 
The analysis results showed that there was 
a direct correlation between patient 
adherence in taking tuberculosis medi-
cation on MDR TB incidence. Treatment 
adherence is important to avoid MDR TB 
and treatment failure. Patient compliance is 
highly demanded in this long-term treat-
ment. Compliance taking this drug is 
needed in all diseases, especially tubercu-
losis disease that requires extra surveillance 
in its treatment (Nurismi, 2014). 
 The study results were consistent with 
Fauziah study (2013) indicates that MDR 
TB patients are more on the subjects of 
non-adherence in treatment than those 
who are obedient. Patients who are 
disobedient have a 10.8-fold chance of 
experiencing MDR TB compared with 
patients who are obedient to their 
treatment. 
 The result of this study was in line 
with Nurismistudy (2014) that there is a 
significant relationship between the level of 
treatment adherence with MDR TB 
incidence in RSUD Labuan Baji Makassar 
and the magnitude of risk can be seen from 
the value OR = 28.02 which means the 
studysubject with the level of adherence 
treatment is not good possibility with MDR 
TB occurred 28 times compared with the 
subjects with good adherence level. 
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 Noncompliance in treatment becomes 
an important factor inresistance develop-
ment. Non-compliance in treatment is 
often underestimated by health personnel 
and difficult to predict. This is probably due 
to many factors that affect it. Certain 
factors, such as morbidity, alcohol con-
sumption, medication consumption and 
vagrants become a non-adherence factor to 
treatment. In addition, complex treatment, 
drug effects and treatment time that took a 
long time to make the patient decided to 
stop taking drugs (Jain and Dixit, 2008). 
2. Relationship between perceptions 
of vulnerability and MDR TB through 
adherence variables 
The results of the analysis indicated that 
there was an indirect relationship between 
susceptibility perception and MDR TB 
incidence through patient compliance 
variable in taking TB medication. 
 One of the models developed to look 
at the factors that influence a person's 
actions to seek a healthy lifestyle is the 
Health Belief Model. HBM was developed 
to explain the failure causes of a group of 
individuals in a disease prevention program 
and expanded to study the person behavior 
against a well-established diagnosis of 
medication adherence issues (Safri et al., 
2014). 
 Vulnerability perception is the way a 
person acts to treat or prevent his illness; 
he must feel that he is susceptible to the 
disease. In other words, a precaution 
against a disease will arise when a person 
has felt that he or his family is susceptible 
to the disease (Nurhayati et al., 2015). 
 The results of Safri et al. (2014) 
showed that there was no relation between 
perception of susceptibility and tuber-
culosis drug adherence observed from p = 
0.998. This means that the perception of 
vulnerability has no relationship with 
compliance if it is not shared with other 
variables. However, this variable will have a 
relationship if it is analyzed together as one 
unity with other variables that are 
perceived susceptibility, feeling seriousness 
(perceived seriousness), perceived benefit 
and perceived barrier. 
 Factors that affect individuals and 
families of tuberculosis patients in seeking 
health care and are adherent to medication 
are the level of education, knowledge, 
attitudes, occupations, income, distance of 
health services and support of drug con-
servers and supported by the role of health 
workers in motivating behavioral change 
(Safri et al ., 2014). 
3. Relationship between Perceptions 
of seriousness and MDR TB through 
adherence variables 
The results of the analysis indicated that 
there was an indirect correlation between 
the perception of seriousness and MDR TB 
incidence through patient compliance 
variable in taking TB medication. 
 The health-faith model is useful for 
estimating noncompliance, which beliefs 
about one's health and personality play a 
role in determining the patient's response 
to treatment recommendations. Individual 
actions for treatment and disease preven-
tion will be driven by the seriousness of the 
disease against individuals or communities. 
In this case, the action taken by tuber-
culosis patients is compliant to take tuber-
culosis medication considering this disease 
is a serious disease and can cause death 
(Safri et al., 2014). 
 The results of Safri et al. (2014) 
showed that there was no correlation 
between the perception of seriousness of 
TB drug adherence observed from p = 
0.998. This means the perception of 
seriousness has no relationship with com-
pliance if it is not shared with other 
variables. However, this variable will have a 
relationship if it is analyzed together as a 
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whole with other variables of perceived 
susceptibility, perceived seriousness, per-
ceived benefit and perceived barrier. 
 Individual actions to treat and prevent 
disease will also be encouraged by the 
seriousness of the disease against indi-
viduals or communities. In this case, the 
actions taken by TB patients are compiled 
to take TB medication, since tuberculosis is 
a serious disease that can cause death. The 
heavier the risk of disease, the more likely 
the individual feels threatened. This threat 
encourages individual action to take 
preventive and healing measures of disease 
(Safri et al., 2014). 
4. Relationship between perceived of 
benefits and MDR TB through 
adherence variables 
The results of the analysis indicated that 
there was an indirect relationship between 
beneficial perception and MDR TB inci-
dence through patient compliance variable 
in taking TB medication. 
 If the individual feels himself vulne-
rable to serious diseases, he will take a 
certain action. This action depends on the 
perceived benefits. Perceiving need for 
action is influenced by variables that affect 
a person's perception and consequently 
indirectly affect his or her health behavior 
(Safri et al., 2014). 
 The results of Safri et al. (2014) 
showed that there was no correlation 
between perception of benefit and tuber-
culosis drug adherence observed from p = 
0.998. This means that the perception of 
benefits has no relationship with com-
pliance if it is not shared with other varia-
bles. However, this variable will have a 
relationship if it is analyzed together as a 
whole with other variables of perceived 
susceptibility, perceived seriousness, per-
ceived benefit and perceived barrier. 
 The study results in line with 
Nurhayati study (2015) state that there is a 
relationship between the perception of 
benefits and the prevention of tuberculosis 
(p <0.05), the more positive the perception 
of MDR TB patients about the usefulness, 
the better the tendency to take action and 
confidence in running the prevention of 
transmission of tuberculosis increasingly. 
5. Relationship between perceived 
barrier and MDR TB through 
adherence 
The analysis results indicated that there 
was an indirect correlation between barrier 
perception and the incidence of MDR TB 
through patient compliance variable in 
taking TB medication. 
 The last forming of HBM is the barrier 
perception to be faced from the action or 
health behavior. However, a person may 
not take anaction, even if the individual 
believes in the benefits of taking such 
action. This could be caused by obstacles. 
Barrier refers to the characteristics of a 
preventive measure such as inconvenient, 
expensive, unpleasant. This characteristic 
will cause the individual to move away from 
the action desired to be performed 
(Nurhayati, 2015). 
 The results of Safri et al. (2014) 
showed that there was no correlation 
between perception of obstacles and TB 
drug adherence observed from p = 0.998. 
This means the perception of obstacles has 
no relationship with compliance if it is not 
shared with other variables. However, this 
variable will have a relationship if it is 
analyzed together as one unity with other 
variables that are perceived susceptibility, 
perceived seriousness, perceived benefit, 
and perceived barrier. 
 One of the factors quite influential on 
compliance to take the drug is the personal 
experience of the studysubject. In this case, 
the personal experience is the experience of 
the side effect of OAT. The side effect itself 
felt by study subjects such as nausea 
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vomiting becomes a person's obstacles in 
drinking OAT. This really affects the 
patient's adherence to take medication, as 
they feel traumatized by the side effects 
that arise after taking the drug (Safri et al., 
2014). 
6. Relationship between the imple-
mentation of DOTS treatment and 
MDR TB. 
The analysis results showed that there was 
a direct relationship between the imple-
mentation of DOTS treatment and the 
incidence of MDR TB. The concept of DOTS 
is one of the important efforts in ensuring 
patient’s treatment regularity and tackling 
MDR TB problem (Syahrini, 2008). 
Intermittent or non-DOTS treatment can 
also result in the emergence of multiple 
immune cases against anti-tuberculosis 
drugs that lead to a stronger type of 
tuberculosis germ known as MDR TB 
(Sarwani et al., 2012). 
 Lack of funding support and facilities 
such as for cultivation and unavailable 
sensitivity are often the main barriers to 
MDR TB control. In addition, guidelines, 
issued by WHO, are often filtered to 
reselect the treatment. Some of the 
program approaches used for the mana-
gement of patient treatment failures may 
fail on some sides, as it can be seen after 
the recording (Fauziah, 2013). 
 The study results in line with study by 
Nurismi (2014) showed that there was no 
significant relationship between the percep-
tion of study subjects on tuberculosis treat-
ment management and MDR TB incidence. 
Management of a good treatment program, 
half of the study subjects of tuberculosis 
and a small part of management of treat-
ment programs, is not good on the subject 
of MDR TB study, because the information 
provided by health workers is very clear 
and the supervision of taking medication 
(PMO) plays a good role. 
 The study results is not in line with 
the study by Zhao et al., (2012) which 
stated that the implementation of 
ineffective tuberculosis treatment with 
DOTS may increase the risk of MDR TB 
incidence with OR = 1.84. In this study, the 
main risk factors of MDR TB in addition to 
poor implementation of DOTS, the bad 
factor of treatment and tuberculosis 
treatment also trigger the incidence of 
MDR TB. Studyby Jain and Dixit (2008) 
showed that a program for controlling 
tuberculosis with first-line therapy and 
DOTS was performed on 467 patients with 
AFB + in a prison. After observation, it was 
concluded that the effectiveness of the 
DOTS program with first-line therapy 
decreased from 85% of target set by WHO. 
The lack of TB infection control in health 
centers and the lack of training from staff is 
also a risk for MDR TB. Mistakes and 
disobedience in prescribing by health 
professionals are frequent and under-
estimated so that it is also difficult to 
precipitate. 
7. Relation between OAT Availability 
and MDR TB through Variables 
between the Implementation of 
DOTS Treatment 
The analysis results indicated that there 
was an indirect relationship between the 
availability of OAT and the incidence of 
MDR TB. Many factors cause MDR TB. 
Some analyzes focus on patient noncom-
pliance. Non-compliance is more associated 
with treatment barriers such as lack of 
diagnostic, drug, transport, logistics and TB 
program control costs. One of the strategies 
contained in the DOTS treatment program 
is the availability of appropriate anti-
tuberculosis drugs including the type, dose 
and time period appropriate to treatment 
therapy (Jain and Dixit, 2008). 
 The study results are in line with 
studies conducted by Zhao et al., (2012) 
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which suggest that poor quality of DOTS 
treatment is associated with poor quality of 
TB treatment (drug type and given dosage) 
that may cause TB patients to be resistant 
to give therapy which increases the risk of 
MDR TB occurrence (OR = 2.65). 
 The results of Mulu et al. (2015) 
showed that the poor treatment and 
inappropriate medication would increase 
the risk of MDR TB.This study also 
revealed that patients who undergo treat-
ment in a non-intensive and continuous 
risk of MDR TB. This is related to bacterial 
death and developmental cycles, as it allows 
the bacteria within the individual to mutate 
and create new genes or bacteria. 
 Fauziah (2013) stated in an obser-
vation conducted among MDR TB patients, 
of 35 patients was a management error in 
28 patients with an average error of 3.93 
per patient. The most common mistakes 
are the addition of unsuccessful drugs, 
failure to identify the existing or existing 
drug resistance, initiation of inadequate 
primary regimens, failure to identify and 
recognize drug nonconformities and 
inaccurate preventive therapy with 
isoniazid. 
8. Relationship between nutritional 
status with MDR TB 
The results showed that there was a direct 
correlation between the nutritional status 
of tuberculosis patients and MDR TB 
incidence. Nutritional status is an 
important part in determining one's health 
level. Nutrition status in addition will affect 
the immune system directly also play a role 
in the healing process of disease including 
patients suffering from tuberculosis 
(Patiung, 2014). Nutritional status is one of 
the main factors causing increased 
morbidity and mortality rate in tuberculosis 
cases (Kumar, 2014). 
 Tuberculosis patients often experience 
a decrease in nutritional status, even it can 
be malnutrition status if it is not balanced 
with proper diet. The study results of 
Patiung et al. (2014) showed that people 
with nutritional status were less likely to 
have 3.7 times more risk to have more 
severe tuberculosis compared with those 
with enough or more nutritional status. 
 Tuberculosis and malnutrition are 
more likely to interact with each other 
(Patiung et al., 2014). Tuberculosis patients 
have poorer nutritional status than healthy 
ones. This can be caused by a decrease in 
appetite in patients with tuberculosis 
(Wokas et al., 2015). 
 The study results in line with the 
study by Muaz (2014) showed that there 
was a relationship between nutritional 
status and the incidence of tuberculosis 
with a value of p = 0.001 and OR = 2.513, 
which means poor nutritional status will 
increase the risk of 2.5 times exposed to 
tuberculosis compared with good 
nutritional status . 
 The study results in line with the 
studyby Fauziah (2013) which shows the 
studysubject suffering from MDR TB is 
more suffered by study subjects who have 
BMI <18.5. Jain (2008) stated that 
underweight TB patients have a higher risk 
for relapse after completion of treatment. 
The low nutritional status also increases the 
failure of TB treatment or develops into 
latent TB infection. Low nutritional status 
can cause germs that proliferate rapidly so 
that it inhibits conversion, but it also causes 
a low immune system making it difficult to 
heal and facilitate recurrence of tuber-
culosis having subsided (Nurismi, 2014). 
 Drug compliance, treatment with 
DOTS strategies and nutritional status of 
tuberculosis patients are directly related to 
MDR TB. Perceptions of vulnerability, 
seriousness, benefits and barriers are 
indirectly associated with MDR TB through 
medication adherence. So it can be 
Aderita et al./ Risk Factors Affecting Multi-Drug Resistant 
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concluded that the perception of patients 
on MDR TB can affect the occurrence of 
MDR TB with the compliance of tuber-
culosis patients in taking the drug. 
 
REFERENCES 
Bhargava A, Chatterjee M, Jain Y, 
Chatterjee B, Kataria A, Bhargava M, 
Kataria R, Souza RD, Jain R, Bene-
detti A, Pai M, Menzies D (2013). 
Nutritional Status of Adult Patients 
with Pulmonary Tuberculosis in Rural 
Central India and Its Association with 
Mortality. Plos one, 8(10): 1-11. 
Erah PO, Ojieabu WA (2009). Success of 
the Control of Tuberculosis in Nigeria 
– A Review. Publisher international 
journal of health study, 2(1):3-14. 
Faustini A, Hall AJ, Perucci CA (2006). 
Risk Factors for Multi Drug Resistant 
Tuberculosis in Europe: A Systematic 
Review. Thorax an International 
Journal of respiratory medicine (61): 
158-116. 
Fauziah LA (2013). Faktor-Faktor Yang 
Berpengaruh terhadap Kejadian Tu-
berkulosis Multidrug Resistant (TB-
MDR) di RSUP Persahabatan Tahun 
2013. Jakarta, Universitas Indonesia. 
Skripsi. 
Jain A, Dixit P (2008). Multidrug Resistant 
to Extensively Drug Resistant Tuber-
culosis: What is Next? Indian Aca-
demy of Sciences, 33(4): 605-616. 
Kemenkes RI (2011). Terobosan Menuju 
Akses Universal: Strategi Nasional 
Pengendalian TB di Indonesia 2010-
2014. Jakarta  
_____ (2014). Pedoman Nasional Pengen-
dalian Tuberkulosis. Jakarta : Kemen-
terian Kesehatan Republik Indonesia. 
_____ (2015). Profil Kesehatan Indonesia 
Tahun 2014. Jakarta : Kementerian 
Kesehatan Republik Indonesia. 
Kumar A, Kakkar R, Kandpal SD, Sindha-
wani G (2014).  Nutritional Status in 
Multi-Drug Resistance Pulmonary 
Tuberculosis Patients. Indian journal 
of community health, 26(2): 204-208. 
Masniari L, Priyanti ZS, Tjandra YA (2007). 
Faktor-Faktor yang Mempengaruhi 
Kesembuhan Penderita TB Paru. 
Jurnal Respiratori Indonesia, 27 (3), 
176-183. 
Maulidia DF (2014). Hubungan Antara Du-
kungan Keluarga dan Kepatuhan Mi-
num Obat pada Penderita Tuberku-
losis di Wilayah Ciputat Tahun 2014. 
Jakarta, Universitas Islam Negeri 
Syarif Hidayatullah Jakarta. Skripsi. 
Muaz F (2014). Faktor-faktor yang Mem-
pengaruhi Kejadian Tuberkulosis 
Paru Basil Tahan Asam Positif di Pus-
kesmas Wilayah Kecamatan Serang. 
Kota Serang Tahun 2014. Jakarta, 
Universitas Islam Negeri Syarif Hida-
yatullah Jakarta. Skripsi. 
Mulu W, Mekonnen D, Yimer M, Admassu 
A, Abera B (2015). Risk Factors for 
Multidrug Resistant Tuberculosis Pa-
tients in Amhara National Regional 
State. African health science, 15(2): 
368-377. 
Nurhayati I, Kurniawan T, Mardiah W 
(2015). Perilaku Pencegahan Penula-
ran dan Faktor-Faktor yang Melatar-
belakanginya pada Pasien Tubercu-
losis Multidrug Resistance (TB MDR). 
Jurnal Keperawatan Padjajaran, 3(3): 
166-175. 
Nurismi (2014). Faktor-Faktor yang Berhu-
bungan dengan Terjadinya Multi 
Drug Resistant pada Pasien Tuber-
kulosis Paru Terhadap Penyembuhan 
di Poliklinik TB MDR RSUD Labuang 
Baji Makasar 2013. Makasar, Univer-
sitas Hasanuddin. Skripsi. 
Paitung F, Wongkar MCP, Mandang V 
(2014). Hubungan Status Gizi dengan 
Journal of Epidemiology and Public Health (2016), 1(2): 86-99 
https://doi.org/jepublichealth.2016.01.02.02 
 
98   e-ISSN: 2549-0273 (online) 
CD4 pada Pasien TB Paru. Jurnal e-
clinic, 2(2):1-7. 
Safri FM, Sukartini T, Ulfiana E (2014). 
Analisis Faktor yang Berhubungan 
dengan Kepatuhan Minum Obat Pasi-
en TB Paru berdasarkan Health Belief 
Model di Wilayah Kerja Puskesmas 
Umbulsari, Kabupaten Jember. Indo-
nesian Journal of Community Health 
Nursing, 2 (2):12-20. 
Sarwani D, Nurlaela S, Zahrotu I (2012). 
Faktor Risiko Multidrug Resistant Tu-
berculosis (MDR TB). Jurnal kesehat-
an masyarakat, 8(1): 60-66. 
Sihombing H (2012). Pola Resistensi Pri-
mer pada Penderita TB Paru Kategori 
I Di RSUP H Adam Malik Medan. 
Jurnal respirologi indonesia. 138-145. 
Syahrini H (2008). Tuberkulosis Paru 
Resistensi Ganda. Medan, Universitas 
Sumatera Utara. Tesis. 
Wokas JAJ, Wongkar MCP, Surachmanto E 
(2015). Hubungan antara Status gizi, 
Sputum BTA dengan Gambaran Ront-
gen Paru pada Pasien Tuberkulosis. 
Jurnal e-clinic. 3 (1):298-305. 
WHO (2014). Global tuberculosis report 
2014. Retrieved from:http://apps.-
who.int/iris/bitstrem/10665/137094/
1/9789241564809_eng.pdf. 
_____ (2015). Global tuberculosis report 
2015. Retrieved from:http://apps.-
who.int/iris/bitstram/10665/191102/
1/9789241565059_eng.pdf. 
Zhao P, Li XJ, Zhang SF, Wang XS, Liu CY 
(2012). Social Behaviour Risk Factors 
for Drug Resistant in Mainland China. 
The journal of international medical 
study. 40: 436-444. 
 
 
 
